vs

Side-by-side financial comparison of CVR ENERGY INC (CVI) and ResMed (RMD). Click either name above to swap in a different company.

CVR ENERGY INC is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× ResMed). ResMed runs the higher net margin — 27.6% vs -8.1%, a 35.7% gap on every dollar of revenue. On growth, CVR ENERGY INC posted the faster year-over-year revenue change (20.3% vs 11.0%). Over the past eight quarters, ResMed's revenue compounded faster (7.8% CAGR vs 0.3%).

CVR Energy Inc is a United States-based energy holding company operating two core segments: petroleum refining and nitrogen fertilizer manufacturing. It produces a wide range of products including gasoline, diesel, jet fuel, and agricultural fertilizers, primarily serving commercial, industrial and agricultural customers across North America.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

CVI vs RMD — Head-to-Head

Bigger by revenue
CVI
CVI
1.4× larger
CVI
$2.0B
$1.4B
RMD
Growing faster (revenue YoY)
CVI
CVI
+9.3% gap
CVI
20.3%
11.0%
RMD
Higher net margin
RMD
RMD
35.7% more per $
RMD
27.6%
-8.1%
CVI
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.8%
0.3%
CVI

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
CVI
CVI
RMD
RMD
Revenue
$2.0B
$1.4B
Net Profit
$-160.0M
$392.6M
Gross Margin
-5.2%
61.8%
Operating Margin
34.6%
Net Margin
-8.1%
27.6%
Revenue YoY
20.3%
11.0%
Net Profit YoY
-56.1%
13.9%
EPS (diluted)
$-1.91
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVI
CVI
RMD
RMD
Q2 26
$1.4B
Q1 26
$2.0B
$1.4B
Q4 25
$1.8B
$1.4B
Q3 25
$1.9B
$1.3B
Q2 25
$1.8B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.9B
$1.3B
Q3 24
$1.8B
$1.2B
Net Profit
CVI
CVI
RMD
RMD
Q2 26
$392.6M
Q1 26
$-160.0M
$398.7M
Q4 25
$-110.0M
$392.6M
Q3 25
$374.0M
$348.5M
Q2 25
$-114.0M
$379.7M
Q1 25
$-123.0M
$365.0M
Q4 24
$28.0M
$344.6M
Q3 24
$-124.0M
$311.4M
Gross Margin
CVI
CVI
RMD
RMD
Q2 26
61.8%
Q1 26
-5.2%
62.2%
Q4 25
-3.1%
61.8%
Q3 25
28.8%
61.5%
Q2 25
-3.7%
60.8%
Q1 25
-5.5%
59.3%
Q4 24
3.0%
58.6%
Q3 24
-3.9%
58.6%
Operating Margin
CVI
CVI
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
-5.3%
34.6%
Q3 25
26.3%
33.4%
Q2 25
-5.8%
33.7%
Q1 25
-8.0%
33.0%
Q4 24
1.1%
32.5%
Q3 24
-6.2%
31.6%
Net Margin
CVI
CVI
RMD
RMD
Q2 26
27.6%
Q1 26
-8.1%
27.9%
Q4 25
-6.1%
27.6%
Q3 25
19.2%
26.1%
Q2 25
-6.5%
28.2%
Q1 25
-7.5%
28.3%
Q4 24
1.4%
26.9%
Q3 24
-6.8%
25.4%
EPS (diluted)
CVI
CVI
RMD
RMD
Q2 26
$2.68
Q1 26
$-1.91
$2.74
Q4 25
$-1.09
$2.68
Q3 25
$3.72
$2.37
Q2 25
$-1.14
$2.58
Q1 25
$-1.22
$2.48
Q4 24
$0.28
$2.34
Q3 24
$-1.24
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVI
CVI
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$512.0M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$6.3B
Total Assets
$3.9B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVI
CVI
RMD
RMD
Q2 26
$1.4B
Q1 26
$512.0M
$1.7B
Q4 25
$511.0M
$1.4B
Q3 25
$670.0M
$1.4B
Q2 25
$596.0M
$1.2B
Q1 25
$695.0M
$932.7M
Q4 24
$987.0M
$521.9M
Q3 24
$534.0M
$426.4M
Total Debt
CVI
CVI
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$1.8B
$403.9M
Q3 25
$1.8B
$408.7M
Q2 25
$1.8B
$658.4M
Q1 25
$1.9B
$663.1M
Q4 24
$1.9B
$662.9M
Q3 24
$1.6B
$667.6M
Stockholders' Equity
CVI
CVI
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$730.0M
$6.3B
Q3 25
$840.0M
$6.1B
Q2 25
$466.0M
$6.0B
Q1 25
$580.0M
$5.5B
Q4 24
$703.0M
$5.3B
Q3 24
$675.0M
$5.2B
Total Assets
CVI
CVI
RMD
RMD
Q2 26
$8.5B
Q1 26
$3.9B
$8.8B
Q4 25
$3.7B
$8.5B
Q3 25
$4.0B
$8.3B
Q2 25
$4.0B
$8.2B
Q1 25
$4.3B
$7.6B
Q4 24
$4.3B
$7.1B
Q3 24
$3.9B
$7.2B
Debt / Equity
CVI
CVI
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
2.40×
0.06×
Q3 25
2.17×
0.07×
Q2 25
3.97×
0.11×
Q1 25
3.29×
0.12×
Q4 24
2.71×
0.13×
Q3 24
2.33×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVI
CVI
RMD
RMD
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$21.0M
FCF MarginFCF / Revenue
1.1%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVI
CVI
RMD
RMD
Q2 26
Q1 26
Q4 25
$0
$339.7M
Q3 25
$163.0M
$457.3M
Q2 25
$176.0M
$538.8M
Q1 25
$-195.0M
$578.7M
Q4 24
$98.0M
$308.6M
Q3 24
$48.0M
$325.5M
Free Cash Flow
CVI
CVI
RMD
RMD
Q2 26
Q1 26
$21.0M
Q4 25
$311.2M
Q3 25
$125.0M
$414.4M
Q2 25
$135.0M
$508.2M
Q1 25
$-246.0M
$557.9M
Q4 24
$43.0M
$288.0M
Q3 24
$14.0M
$307.7M
FCF Margin
CVI
CVI
RMD
RMD
Q2 26
Q1 26
1.1%
Q4 25
21.9%
Q3 25
6.4%
31.0%
Q2 25
7.7%
37.7%
Q1 25
-14.9%
43.2%
Q4 24
2.2%
22.5%
Q3 24
0.8%
25.1%
Capex Intensity
CVI
CVI
RMD
RMD
Q2 26
Q1 26
1.5%
Q4 25
3.0%
2.0%
Q3 25
2.0%
3.2%
Q2 25
2.3%
2.3%
Q1 25
3.1%
1.6%
Q4 24
2.8%
1.6%
Q3 24
1.9%
1.5%
Cash Conversion
CVI
CVI
RMD
RMD
Q2 26
Q1 26
Q4 25
0.87×
Q3 25
0.44×
1.31×
Q2 25
1.42×
Q1 25
1.59×
Q4 24
3.50×
0.90×
Q3 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons